Vesper Bio
About:
Vesper Bio is a clinical-stage biotechnology company.
Website: https://www.vesperbio.com
Top Investors: Michael J. Fox Foundation
Description:
Vesper Bio is a clinical-stage biotechnology company that makes an observation that may enable the development of a cure/treatment against a devastating or fatal disorder.
Total Funding Amount:
$873000
Headquarters Location:
Copenhagen, Hovedstaden, Denmark
Founded Date:
2013-01-01
Contact Email:
info(AT)vesperbio.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-01-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai